Entrada Therapeutics Reports First Quarter 2026 Financial Results

Go back to Entrada Therapeutics Reports First Quarter 2026 Financial Results
(NASDAQ: TRDA) Delayed: 6.60 --0 (-0%)
Previous Close $6.60    52 Week High
Open $6.60    52 Week Low
Day High $6.60    P/E N/A 
Day Low $6.60    EPS
Volume 1,426